EC Nutrition

COVID19 virus, which carries genes from unrelated phylogenetic origin (such as human bat and avian) is a causative agent of severe acute respiratory syndrome. It primarily targets the respiratory system, but can cause extrapulmonary manifestations that can lead to severe complications and death both with and without these complications. The use of vaccines, immunotherapy, and steroids is not considerably effective against COVID 19 virus driven manifestations because COVID 19 virus uses an unusual strategy to cause illness by targeting cells in different tissues of human body systems presenting as a syndrome. COVID 19 virus pandemic resulted in 20 million deaths worldwide. The use of diet preparations designed by using novel scientific findings, as reported by Rab (2007), eradicated COVID 19 virus pandemic in Pakistan and several other global regions, saving countless lives. In this paper knowledge built on reported work by Rab (2007) is used to demonstrate the unusual strategy that COVID 19 virus uses to cause illness manifestations. In addition the scientific narratives have been presented in support with suggested molecular mechanisms, indicating that use of appropriate food preparations is an effective therapy for COVID 19 virus driven illness. This is evidenced from the fact that Rab’s designed diet preparations helped to eradicating COVID19 virus pandemic in Pakistan and many other parts of globe. In addition to the details previously mentioned, this paper reports several food preparations that can enhance digestion and absorption of healing food contents. These diet preparations utilize a novel strategy to prevent COVID 19 virus driven complications, combat premature aging, accelerate natural healing and ultimately help recovering patients regain their natural health.

 Keywords: Molecular Mechanism Underlying COVID 19 Driven Illness; Epigenetics; Evolution; Food; Genes Regulatory Networks; Natural Health

1. Alanagreh L., et al. “The human coronavirus disease COVID-19: Its origin, characteristics, and insights into potential drugs and its mechanisms”. Pathogens (Basel, Switzerland)5 (2020): 331.
2. Hu B., et al. “Bat origin of human coronaviruses”. Virology Journal 12 (2015): 221.
3. Ochani R., et al. “COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management”. Le Infezioni in Medicina1 (2021): 20-36.
4. Bakadia BM., et al. “The impact of oxidative stress damage induced by the environmental stressors on COVID-19”. Life Sciences 264 (2021): 118653.
5. Sette A and Crotty S. “Adaptive immunity to SARS-CoV-2 and COVID-19”. Cell4 (2021): 861-880.
6. Sinha S., et al. “Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19”. Nature Medicine1 (2022): 201-211.
7. Zhang JJ., et al. “Risk and protective factors for COVID-19 morbidity, severity, and mortality”. Clinical Reviews in Allergy and Immunology1 (2023): 90-107.
8. Parasher A. “COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment”. Postgraduate Medical Journal1147 (2021): 312-320.
9. Rahman S., et al. “Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence”. Expert Review of Clinical Pharmacology5 (2021): 601-621.
10. Kakovan M., et al. “Stroke associated with COVID-19 vaccines”. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association6 (2022): 106440.
11. Franchini M., et al. “COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome”. European Journal of Haematology2 (2021): 173-180.
12. Albini A., et al. “The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies”. Internal and Emergency Medicine5 (2020): 759-766.
13. Gupta A., et al. “Extrapulmonary manifestations of COVID-19”. Nature Medicine7 (2020): 1017-1032.
14. Connors JM and Levy JH. “COVID-19 and its implications for thrombosis and anticoagulation”. Blood23 (2020): 2033-2040.
15. Bansal M. “Cardiovascular disease and COVID-19”. Diabetes and Metabolic Syndrome3 (2020): 247-250.
16. Sawalha K., et al. “Systematic review of COVID-19 related myocarditis: insights on management and outcome”. Cardiovascular Revascularization Medicine: Including Molecular Interventions 23 (2021): 107-113.
17. Ertuğlu LA., et al. “COVID-19 and acute kidney injury. COVID-19 ve akut böbrek hasarı”. Tuberkuloz ve Toraks4 (2020): 407-418.
18. Cao TT., et al. “COVID-19 and its effects on the digestive system”. World Journal of Gastroenterology24 (2021): 3502-3515.
19. Ristic-Medic D., et al. “Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition”. World Journal of Gastroenterology34 (2021): 5682-5699.
20. Paul AK., et al. “Does oxidative stress management help alleviation of COVID-19 symptoms in patients experiencing diabetes?”. Nutrients2 (2022): 321.
21. Hingorani KS., et al. “COVID-19 and the brain”. Trends in Cardiovascular Medicine6 (2022): 323-330.
22. Chaudhury SS., et al. “COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation”. Journal of Biosciences2 (2021): 47.
23. Paterson RW., et al. “The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings”. Brain: A Journal of Neurology10 (2020): 3104-3120.
24. Jones EAK., et al. “Impact of COVID-19 on mental health in adolescents: A systematic review”. International Journal of Environmental Research and Public Health5 (2021): 2470.
25. Scappaticcio L., et al. “Impact of COVID-19 on the thyroid gland: an update”. Reviews in Endocrine and Metabolic Disorders 4 (2021): 803-815.
26. Venter C., et al. “Erythrocyte, platelet, serum ferritin, and p-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19”. International Journal of Molecular Sciences21 (2020): 8234.
27. Wang CL., et al. “Impact of COVID-19 on pregnancy”. International Journal of Medical Sciences3 (2021): 763-767.
28. Schultze JL and Aschenbrenner AC. “COVID-19 and the human innate immune system”. Cell 7 (2021): 1671-1692.
29. Al Amir Dache Z., et al. “Blood contains circulating cell-free respiratory competent mitochondria”. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology3 (2020): 3616-3630.
30. Stier A. “Human blood contains circulating cell-free mitochondria, but are they really functional?”. American Journal of Physiology. Endocrinology and Metabolism5 (2021): E859-E863.
31. Amaral EP., et al. “A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis”. The Journal of Experimental Medicine3 (2019): 556-570.
32. Kaniak-Golik A and Skoneczna A. “Mitochondria-nucleus network for genome stability”. Free Radical Biology and Medicine 82 (2015): 73-104.
33. Garcia I., et al. “The little big genome: the organization of mitochondrial DNA”. Frontiers in Bioscience (Landmark Edition) 4 (2017): 710-721.
34. Tsang CK., et al. “Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance”. Nature Communications 5 (2014): 3446.
35. Zorov DB., et al. “Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release”. Physiological Reviews3 (2014): 909-950.
36. Vollbracht C and Kraft K. “Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: Implications for the benefit of high-dose intravenous vitamin C”. Frontiers in Pharmacology 13 (2022): 899198.
37. Chernyak BV., et al. “COVID-19 and oxidative stress”. Biokhimiia 85.12 (2020): 1543-1553.
38. Hargreaves IR and Mantle D. “COVID-19, coenzyme Q10 and selenium”. Advances in Experimental Medicine and Biology 1327 (2021): 161-168.
39. van Eijk LE., et al. “Mild coronavirus disease 2019 (COVID-19) is marked by systemic oxidative stress: A pilot study”. Antioxidants (Basel, Switzerland)12 (2021): 2022.
40. Itri R., et al. “Membrane changes under oxidative stress: the impact of oxidized lipids”. Biophysical Reviews1 (2014): 47-61.
41. Suhail S., et al. “Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: A review”. The Protein Journal6 (2020): 644-656.
42. Ascenzi P., et al. “Hemoglobin and heme scavenging”. IUBMB Life11 (2005): 749-759.
43. Zhang H and Feng T. “Network-based data analysis reveals ion channel-related gene features in COVID-19: A bioinformatic approach”. Biochemical Genetics2 (2023): 471-505.
44. Faiza Abdur Rab. Phenotypic variation in stress resistance between individual cells in isogenic populations of Saccharomyces cerevisiae was submitted at University of Nottingham United Kingdom which was funded by National Institute of Health (NIH) US Department of Health and Human Services whereas Full PhD Tuition Fees was supported by Developing Solution PhD Tuition Fees Scholarship 2003 offered by University of Nottingham, United Kingdom and boarding and lodging was supported for two years only by University of Karachi Pakistan’s Overseas PhD Scholarship Scheme 2003 (2007).
45. Bishop AL., et al. “Phenotypic heterogeneity can enhance rare-cell survival in 'stress-sensitive' yeast populations”. Molecular Microbiology 2 (2007): 507-520.
46. Sumner ER and Avery SV. “Phenotypic heterogeneity: differential stress resistance among individual cells of the yeast Saccharomyces cerevisiae”. Microbiology (Reading, England)2 (2002): 345-351.
47. Vallières C., et al. “Mitochondrial ferredoxin determines vulnerability of cells to copper excess”. Cell Chemical Biology 10 (2017): 1228-1237.e3.
48. Sumner ER., et al. “Cell cycle- and age-dependent activation of Sod1p drives the formation of stress resistant cell subpopulations within clonal yeast cultures”. Molecular Microbiology3 (2003): 857-870.
49. Holland SL and Avery SV. “Actin-mediated endocytosis limits intracellular Cr accumulation and Cr toxicity during chromate stress”. Toxicological Sciences: An Official Journal of the Society of Toxicology2 (2009): 437-446.
50. Rab FA. “Environmentally modulated evolution through genetic regulation”. Information Systems for Biotechnology. ISB News Reports Virginia Tech June/July (2014).
51. Libby P and Lüscher T. “COVID-19 is, in the end, an endothelial disease”. European Heart Journal32 (2020): 3038-3044.
52. Xu SW., et al. “Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies”. Acta Pharmacologica Sinica4 (2023): 695-709.
53. Zhao H., et al. “Dynamic imaging of cellular pH and redox homeostasis with a genetically encoded dual-functional biosensor, pHaROS, in yeast”. The Journal of Biological Chemistry43 (2019): 15768-15780.
54. Ferreira ID., et al. “Is the expression of genes encoding enzymes of glutathione (GSH) metabolism involved in chloroquine resistance in Plasmodium chabaudi parasites?”. Molecular and Biochemical Parasitology1 (2004): 43-50.
55. Klouda CB and Stone WL. “Oxidative stress, proton fluxes, and chloroquine/hydroxychloroquine treatment for COVID-19”. Antioxidants (Basel, Switzerland)9 (2020): 894.
56. Islahudin F., et al. “Reply to "chloroquine, an antifungal but also a fertility drug". Antimicrobial Agents and Chemotherapy11 (2013): 5787.
57. Kim J., et al. “Absorption of manganese and iron in a mouse model of hemochromatosis”. PloS one5 (2013): e64944.
58. Jouihan HA., et al. “Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis”. Molecular Medicine (Cambridge, Mass)3-4 (2008): 98-108.
59. Skalny AV., et al. “Zinc and respiratory tract infections: Perspectives for COVID 19 (Review)”. International Journal of Molecular Medicine1 (2020): 17-26.
60. Manes TL and Cota-Gomez A. “Mechanisms of HIV-1 tat-mediated regulation of the manganese-superoxide dismutase promoter”. Free Radical Biology and Medicine 100 (2016): S58.
61. Henning Y., et al. “Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction”. Cell Death and Disease7 (2022): 662.
62. Yetkin-Arik B., et al. “The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis”. Scientific Reports1 (2019): 12608.
63. Young A., et al. “Lactate dehydrogenase supports lactate oxidation in mitochondria isolated from different mouse tissues”. Redox Biology 28 (2020): 101339.
64. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet (London, England) 10223 (2020): 497-506.
65. Dixon SJ., et al. “Ferroptosis: an iron-dependent form of nonapoptotic cell death”. Cell5 (2012): 1060-1072.
66. Dixon SJ and Stockwell BR. “The role of iron and reactive oxygen species in cell death”. Nature Chemical Biology1 (2014): 9-17.
67. Stockwell BR and Jiang X. “The chemistry and biology of ferroptosis”. Cell Chemical Biology4 (2020): 365-375.
68. Edeas M., et al. “Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?”. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 97 (2020): 303-305.
69. Su Y., et al. “Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19”. Cell 6 (2020): 1479-1495.e20.
70. Abudugupur A., et al. “Severe reduction of superoxide dismutase activity in the yeast Saccharomyces cerevisiae with the deletion or overexpression of GTS1”. FEMS Microbiology Letters1 (2003): 141-145.
71. Alarcón OM., et al. “Changes of serum lipids in vitamin K3 (menadione) treated rats”. Archivos Latinoamericanos de Nutricion4 (1995): 286-289.
72. Steinmeier J and Dringen R. “Exposure of cultured astrocytes to menadione triggers rapid radical formation, glutathione oxidation and Mrp1-mediated export of glutathione disulfide”. Neurochemical Research5 (2019): 1167-1181.
73. Brasil AA., et al. “The involvement of GSH in the activation of human Sod1 linked to FALS in chronologically aged yeast cells”. FEMS Yeast Research5 (2013): 433-440.
74. Tan SX., et al. “Cu, Zn superoxide dismutase and NADP(H) homeostasis are required for tolerance of endoplasmic reticulum stress in Saccharomyces cerevisiae”. Molecular Biology of the Cell5 (2009): 1493-1508.
75. Paolisso G., et al. “Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics”. The American Journal of Physiology3.1 (1992): E435-E440.
76. Barbagallo M., et al. “Effects of vitamin E and glutathione on glucose metabolism: Role of magnesium”. Hypertension (Dallas, Tex.) 19794.2 (1999): 1002-1006.
77. Sturtz LA., et al. “A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage”. The Journal of Biological Chemistry41 (2001): 38084-38089.
78. Niang I., et al. “False ground-glass opacity and suspicion of COVID-19, beware of the technique for performing the CT”. The Pan African Medical Journal2 (2020): 138.
79. Fukui M and Zhu BT. “Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells”. Free Radical Biology and Medicine6 (2010): 821-830.
80. Hackler J., et al. “Relation of serum copper status to survival in COVID-19”. Nutrients6 (2021): 1898.
81. Govind V., et al. “Antiviral properties of copper and its alloys to inactivate covid-19 virus: A review”. Biometals 6 (2021): 1217-1235.
82. Raha S., et al. “Is copper beneficial for COVID-19 patients?”. Medical Hypotheses 142 (2020): 109814.
83. Clark NF and Taylor-Robinson AW. “COVID-19 therapy: could a copper derivative of chlorophyll a be used to treat lymphopenia associated with severe symptoms of SARS-CoV-2 infection?”. Frontiers in Medicine 8 (2021): 620175.
84. Francis Z., et al. “The COVID-19 pandemic and zinc-induced copper deficiency: an important link”. The American Journal of Medicine8 (2022): e290-e291.
85. Zhou B and Gitschier J. “hCTR1: a human gene for copper uptake identified by complementation in yeast”. Proceedings of the National Academy of Sciences of the United States of America14 (1997): 7481-7486.
86. De Feo CJ., et al. “Three-dimensional structure of the human copper transporter hCTR1”. Proceedings of the National Academy of Sciences of the United States of America11 (2009): 4237-4242.
87. Maryon EB., et al. “Rate and regulation of copper transport by human copper transporter 1 (hCTR1)”. The Journal of Biological Chemistry25 (2013): 18035-18046.
88. Rock E., et al. “The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in middle-aged healthy volunteers”. Free Radical Biology and Medicine3 (2000): 324-329.
89. Scott MD., et al. “Enhancement of erythrocyte superoxide dismutase activity: effects on cellular oxidant defense”. Blood7 (1989): 2542-2549.
90. Leitch JM., et al. “Post-translational modification of Cu/Zn superoxide dismutase under anaerobic conditions”. Biochemistry2 (2012): 677-685.
91. Peggion C., et al. “SOD1 in ALS: Taking stock in pathogenic mechanisms and the role of glial and muscle cells”. Antioxidants (Basel, Switzerland)4 (2022): 614.
92. Kozakiewicz M., et al. “Changes in the blood antioxidant defense of advanced age people”. Clinical Interventions in Aging 14 (2019): 763-771.
93. Nilsson R., et al. “Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis”. Cell Metabolism2 (2009): 119-130.
94. Saito T. “Superoxide dismutase level in human erythrocytes and its clinical application to the patients with cancers and thyroidal dysfunctions”. [Hokkaido Igaku Zasshi] The Hokkaido Journal of Medical Science2 (1987): 257-268.
95. Kim MJ., et al. “Exploring the role of copper and selenium in the maintenance of normal thyroid function among healthy Koreans”. Journal of Trace Elements in Medicine and Biology 61 (2020): 126558.
96. Iuchi Y., et al. “Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production”. The Biochemical Journal2 (2007): 219-227.
97. Damiano S., et al. “Metabolism regulation and redox state: Insight into the role of superoxide dismutase 1”. International Journal of Molecular Sciences18 (2020): 6606.
98. Boggs SE., et al. “Glutathione levels determine apoptosis in macrophages”. Biochemical and Biophysical Research Communications 2 (1998): 229-233.
99. Circu ML and Aw TY. “Glutathione and apoptosis”. Free Radical Research8 (2008): 689-706.
100. McCay PB., et al. “Glutathione-dependent inhibition of lipid peroxidation by a soluble, heat-labile factor not glutathione peroxidase”. Federation Proceedings2 (1981): 199-205.
101. Ursini F and Maiorino M. “Lipid peroxidation and ferroptosis: The role of GSH and GPx4”. Free Radical Biology and Medicine 152 (2020): 175-185.
102. Ghezzi P. “Role of glutathione in immunity and inflammation in the lung”. International Journal of General Medicine 4 (2011): 105-113.
103. Benedusi V., et al. “The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis”. The Journal of Biological Chemistry43 (2012): 35899-35911.
104. Cwiklik L and Jungwirth P. “Massive oxidation of phospholipid membranes leads to pore creation and bilayer disintegration”. Chemical Physics Letters 486 (2010): 99-103.
105. Demel RA., et al. “The effect of sterol structure on the permeability of lipomes to glucose, glycerol and Rb +”. Biochimica et Biophysica Acta1 (1972): 321-330.
106. Saleh J., et al. “Mitochondria and microbiota dysfunction in COVID-19 pathogenesis”. Mitochondrion 54 (2020): 1-7.
107. Sukocheva OA., et al. “Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome”. Journal of Advanced Research 40 (2022): 179-196.
108. Cooney J., et al. “COVID-19 infection causing residual gastrointestinal symptoms - a single UK centre case series”. Clinical Medicine (London, England)2 (2022): 181-183.
109. Hernández-Ochoa B., et al. “COVID-19 in G6PD-deficient Patients, Oxidative Stress, and Neuropathology”. Current Topics in Medicinal Chemistry16 (2022): 1307-1325.
110. Zhang F., et al. “Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications”. Nature Reviews. Gastroenterology and Hepatology5 (2023): 323-337.
111. Holland SL., et al. “Candida argentea nov., a copper and silver resistant yeast species”. Fungal Biology 115.9 (2011): 909-918.
112. Reiken S., et al. “Alzheimer's-like signaling in brains of COVID-19 patients”. Alzheimer's and Dementia5 (2022): 955-965.
113. Jarrott B., et al. “"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy”. Pharmacology Research and Perspectives 1 (2022): e00911.
114. Ceban F., et al. “Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis”. Brain, Behavior, and Immunity 101 (2022): 93-135.
115. Pierce JD., et al. “Post-COVID-19 syndrome”. Nursing Research2 (2022): 164-174.
116. Piazza M., et al. “Long COVID-19 in children: From the pathogenesis to the biologically plausible roots of the syndrome”. Biomolecules4 (2022): 556.
117. Anaya JM., et al. “Post-COVID syndrome. A case series and comprehensive review”. Autoimmunity Reviews11 (2021): 102947.
118. Castanares-Zapatero D., et al. “Pathophysiology and mechanism of long COVID: a comprehensive review”. Annals of Medicine1 (2022): 1473-1487.
119. Kerwin BA., et al. “Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications”. Journal of Pharmaceutical Sciences1 (1999): 79-88.
120. Muller MP., et al. “Characterization of lipid-protein interactions and lipid-mediated modulation of membrane protein function through molecular simulation”. Chemical Reviews9 (2019): 6086-6161.
121. Robinett NG., et al. “Eukaryotic copper-only superoxide dismutases (SODs): A new class of SOD enzymes and SOD-like protein domains”. The Journal of Biological Chemistry13 (2018): 4636-4643.
122. Hornedo-Ortega R., et al. “Melatonin and other tryptophan metabolites produced by yeasts: implications in cardiovascular and neurodegenerative diseases”. Frontiers in Microbiology 6 (2016): 1565.
123. Souza CM., et al. “A stable yeast strain efficiently producing cholesterol instead of ergosterol is functional for tryptophan uptake, but not weak organic acid resistance”. Metabolic Engineering5 (2011): 555-569.
124. Holland SL., et al. “Chromate-induced sulfur starvation and mRNA mistranslation in yeast are linked in a common mechanism of Cr toxicity”. Toxicology In Vitro6 (2010): 1764-1767.
125. Payne T., et al. “Transcript-specific translational regulation in the unfolded protein response of Saccharomyces cerevisiae”. FEBS Letters4 (2008): 503-509.
126. Bergman A and Siegal ML. “Evolutionary capacitance as a general feature of complex gene networks”. Nature 6948 (2003): 549-552.
127. Smith MC., et al. “Glutathione and Gts1p drive beneficial variability in the cadmium resistances of individual yeast cells”. Molecular Microbiology3 (2007): 699-712.
128. Sumner ER., et al. “Oxidative protein damage causes chromium toxicity in yeast”. Microbiology (Reading, England)6 (2005): 1939-1948.
129. Avery SV. “Cell individuality: the bistability of competence development”. Trends in Microbiology10 (2005): 459-462.
130. Avery SV. “Microbial cell individuality and the underlying sources of heterogeneity”. Nature Reviews. Microbiology8 (2006): 577-587.
131. Sideri TC., et al. “Methionine sulphoxide reductases protect iron-sulphur clusters from oxidative inactivation in yeast”. Microbiology (Reading, England)2 (2009): 612-623.
132. Stratford M., et al. “Extreme osmotolerance and halotolerance in food-relevant yeasts and the role of glycerol-dependent cell individuality”. Frontiers in Microbiology 9 (2019): 3238.
133. Stratford M., et al. “The preservative sorbic acid targets respiration, explaining the resistance of fermentative spoilage yeast species”. mSphere3 (2020): e00273-20.
134. Avery SV. “Metal toxicity in yeasts and the role of oxidative stress”. Advances in Applied Microbiology 49 (2001): 111-142.
135. Shanmuganathan A., et al. “Copper-induced oxidative stress in Saccharomyces cerevisiae targets enzymes of the glycolytic pathway”. FEBS Letters1-3 (2004): 253-259.
136. Alhebshi A., et al. “The essential iron-sulfur protein Rli1 is an important target accounting for inhibition of cell growth by reactive oxygen species”. Molecular Biology of the Cell18 (2012): 3582-3590.
137. Mollinedo F. “Lipid raft involvement in yeast cell growth and death”. Frontiers in Oncology 2 (2012): 140.
138. Mason RP. “Molecular mechanisms underlying the effects of cholesterol on neuronal cell membrane function and drug-membrane interactions”. In M. Hillbrand and R. T. Spitz (Eds.: Lipids, health, and behavior) American Psychological Association (1997): 127-138.
139. Yang F., et al. “Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes”. Toxicology In Vitro 54 (2019): 310-316.
140. Silja K., et al. “Inhibition of glutathione generation in hepatic steatotic rats augments oxidative stress”. Toxicology Mechanisms and Methods7 (2023): 596-606.
141. Luu W., et al. “Oxysterols: Old tale, new twists”. Annual Review of Pharmacology and Toxicology 56 (2016): 447-467.
142. de Freitas FA., et al. “Impact of oxysterols on cell death, proliferation, and differentiation induction: Current status”. Cells 9 (2021): 2301.
143. Fernández-Beltrán LC., et al. “A transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of SOD1 mice”. International Journal of Molecular Sciences17 (2021): 9553.
144. Delgado-Roche L and Mesta F. “Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection”. Archives of Medical Research5 (2020): 384-387.
145. Rab FA. “Eat fresh live young”. EC Nutrition01 (2017): 03-05.
146. Rab FA. “Is sugar an accessory or necessary”. EC Nutrition4 (2018): 236-237.
147. Rab F A. “Drug-disease relationship and role of the food in healthy living review paper”. EC Nutrition8 (2018): 543-548.
148. Rab FA. “Genome-nutrifortified diets-their disease protection and remedy potential”. Journal of Probiotics and Health 6 (2018): 204.
149. Rab FA. “Is hunger more dangerous than having malnutrition or consuming unsafe diet”. EC Nutrition12 (2019): 01-05.
150. Rab FA. “Halal or Haram-new challenges for religious scholars Muslim world and food supply chain stake holders”. International Journal of Nutritional Science and Food Technology 6 (2020): 3.
151. Rab FA. “Food items biologically tailored to meet nutritional deficiency challenge during Covid 19 Pandemic”. Journal of Probiotics and Health 9 (2021): 233.
152. Abdur Rab F and Hassan A. “Tourism, health promoting food domain and technology applications: individual’s genes reservoir, environmental change and food in natural health context”. In: Hassan, A. (eds) Handbook of Technology Application in Tourism in Asia. Springer, Singapore (2022).
153. Reddy VS., et al. “Nutrigenomics: Opportunities & challenges for public health nutrition”. The Indian Journal of Medical Research 5 (2018): 632-641.
154. “Ibuprofen and coronavirus: What is the connection-if any-according to health experts” 24 March (2020).
155. “Diet for Covid 19” 12 May (2020).
156. Daily Pakistan. Corona Virus-Our fight or Flight 22 March (2020).
157. Seyhanli ES., et al. “Asprosin and oxidative stress in COVID-19 patients”. Clinical Laboratory1 (2022).
158. Duerrschmid C., et al. “Asprosin is a centrally acting orexigenic hormone”. Nature Medicine12 (2017): 1444-1453.
159. Spagnuolo MS., et al. “A short-term western diet impairs cholesterol homeostasis and key players of beta amyloid metabolism in brain of middle aged rats”. Molecular Nutrition and Food Research16 (2020): e2000541.
160. Valenzuela A., et al. “Cholesterol oxidation: health hazard and the role of antioxidants in prevention”. Biological Research3-4 (2003): 291-302.
161. Sharifi-Rad M., et al. “Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases”. Frontiers in Physiology 11 (2020): 694.
162. Camp OG., et al. “Melatonin interferes with COVID-19 at several distinct ROS-related steps”. Journal of Inorganic Biochemistry 223 (2021): 111546.
163. Song J., et al. “The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury”. Oxidative Medicine and Cellular Longevity (2014): 639531.
164. Salehi B., et al. “Melatonin in medicinal and food plants: Occurrence, bioavailability, and health potential for humans”. Cells7 (2019): 681.
165. Sengupta P., et al. “COVID-19, oxidative stress, and male reproductive dysfunctions: is vitamin C a potential remedy?”. Physiological Research1 (2022): 47-54.
166. De Flora S., et al. “Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19”. FASEB Journal 10 (2020): 13185-13193.
167. Alwazeer D., et al. “Combating oxidative stress and inflammation in COVID-19 by molecular hydrogen therapy: mechanisms and perspectives”. Oxidative Medicine and Cellular Longevity (2021): 5513868.
168. Mrityunjaya M., et al. “Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19”. Frontiers in Immunology 11 (2020): 570122.
169. Trujillo-Mayol I., et al. “Western dietary pattern antioxidant intakes and oxidative stress: Importance during the SARS-CoV-2/COVID-19 pandemic”. Advances in Nutrition (Bethesda, Md.)3 (2021): 670-681.
170. Turner AJ. “ACE2 Cell Biology, Regulation, and Physiological Functions”. The Protective Arm of the Renin Angiotensin System (RAS) (2015): 185-189.
171. Moreno-Fernandez J., et al. “Inflammation and oxidative stress, the links between obesity and COVID-19: A narrative review”. Journal of Physiology and Biochemistry3 (2022): 581-591.
172. Diaz-Parga P., et al. “Chemistry and chemical equilibrium dynamics of BMAA and its carbamate adducts”. Neurotoxicity Research1 (2018): 76-86.
173. Glover WB., et al. “Reactivity of β-methylamino-L-alanine in complex sample matrixes complicating detection and quantification by mass spectrometry”. Analytical Chemistry18 (2012): 7946-7953.
174. Müller S., et al. “Paenilamicin: structure and biosynthesis of a hybrid nonribosomal peptide/polyketide antibiotic from the bee pathogen Paenibacillus larvae”. Angewandte Chemie (International Edition in English)40 (2014): 10821-10825.
175. Zecca L., et al. “Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics”. Trends in Neurosciences11 (2003): 578-580.
176. Jimbow K. “Current update and trends in melanin pigmentation and melanin biology”. The Keio Journal of Medicine1 (1995): 9-18.
177. Mårs U and Larsson BS. “Pheomelanin as a binding site for drugs and chemicals”. Pigment Cell Research4 (1999): 266-274.
178. Tribl F., et al. “Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis”. Journal of Neural Transmission. Supplementum 72 (2007): 51-55.
179. Zucca FA., et al. “Neuromelanin of the human substantia nigra: an update”. Neurotoxicity Research1 (2014): 13-23.
180. Zecca L., et al. “New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals”. Proceedings of the National Academy of Sciences of the United States of America45 (2008): 17567-17572.
181. Wakamatsu K., et al. “Biosynthetic pathway to neuromelanin and its aging process”. Pigment Cell and Melanoma Research6 (2012): 792-803.
182. Krone B. “The why of sporadic motor neuron disease—many factors, still a mystery?”. Journal of Neurology and Neuromedicine 1 (2016): 1-5.
183. Zucca FA., et al. “Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease”. Progress in Neurobiology 155 (2017): 96-119.
184. McManus MJ., et al. “The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease”. The Journal of Neuroscience44 (2011): 15703-15715.
185. Lastres-Becker I., et al. “α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease”. Human Molecular Genetics14 (2012): 3173-3192.
186. Dariani S., et al. “Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy”. Journal of Molecular Neuroscience3 (2013): 679-686.
187. An T., et al. “Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS”. Molecular Neurobiology3 (2014): 1435-1448.
188. Eleuteri S., et al. “Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease”. Neurobiology of Disease 74 (2015): 144-157.
189. Miyazato S., et al. “Promotive effects of resistant maltodextrin on apparent absorption of calcium, magnesium, iron and zinc in rats”. European Journal of Nutrition3 (2010): 165-171.
190. Johnson RJ., et al. “Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughts”. Journal of Internal Medicine3 (2020): 252-262.
191. Tappy L. “Health implications of fructose consumption in humans”. In: Mérillon, JM., Ramawat, K. (eds) Sweeteners. Reference Series in Phytochemistry. Springer, Cham (2018).
192. Sun SZ and Empie MW. “Fructose metabolism in humans - what isotopic tracer studies tell us”. Nutrition and Metabolism1 (2012): 89.
193. Zhao M., et al. “D-mannose acts as a V-ATPase inhibitor to suppress inflammatory cytokines generation and bacterial killing in macrophage”. Molecular Immunology 162 (2023): 84-94.
194. Ajibola A., et al. “Nutraceutical values of natural honey and its contribution to human health and wealth”. Nutrition and Metabolism 9 (2012): 61.
195. Eteraf-Oskouei T and Najafi M. “Traditional and modern uses of natural honey in human diseases: a review”. Iranian Journal of Basic Medical Sciences6 (2013): 731-742.
196. Olaitan PB., et al. “Honey: a reservoir for microorganisms and an inhibitory agent for microbes”. African Health Sciences3 (2007): 159-165.
197. Piskin E., et al. “Iron absorption: Factors, limitations, and improvement methods”. ACS Omega24 (2022): 20441-20456.
198. Mehta P., et al. “COVID-19: consider cytokine storm syndromes and immunosuppression”. Lancet (London, England)10229 (2020): 1033-1034.
199. Khomich OA., et al. “Redox biology of respiratory viral infections”. Viruses8 (2018): 392.
200. van den Brand JM., et al. “The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models”. Journal of Comparative Pathology1 (2014): 83-112.
201. Bessman NJ., et al. “Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing”. Science (New York, N.Y.)6487 (2020): 186-189.
202. Schlessinger A., et al. “Protein disorder--a breakthrough invention of evolution?” Current Opinion in Structural Biology3 (2011): 412-418.
203. Hollander D and Ruble PE Jr. “beta-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport”. The American Journal of Physiology 6 (1978): E686-E691.
204. Tavallali V., et al. “Iron nano-complexes and iron chelate improve biological activities of sweet basil (Ocimum basilicum )”. Plant Physiology and Biochemistry 144 (2019): 445-454.
205. Calderón Bravo H., et al. “Basil seeds as a novel food, source of nutrients and functional ingredients with beneficial properties: a review”. Foods (Basel, Switzerland)7 (2021): 1467.
206. Gursoy N., et al. “Antioxidant activities, metal contents, total phenolics and flavonoids of seven Morchella species”. Food and Chemical Toxicology9 (2009): 2381-2388.
207. Singh P., et al. “Nausea: a review of pathophysiology and therapeutics”. Therapeutic Advances in Gastroenterology1 (2016): 98-112.
208. Sandesh P., et al. “Antioxidant activities of tamarind (Tamarindus Indica) seed coat extracts using in vitro and in vivo models”. Journal of Food Science and Technology9 (2014): 1965-1973.
209. Okello J., et al. “Mineral composition of Tamarindus indica LINN (tamarind) pulp and seeds from different agro-ecological zones of Uganda”. Food Science and Nutrition5 (2017): 959-966.
210. Okello J., et al. “Physicochemical composition of Tamarindus indica (Tamarind) in the agro-ecological zones of Uganda”. Food Science and Nutrition 6.5 (2018): 1179-1189.
211. Shao H., et al. “Composition and rheological properties of polysaccharide extracted from tamarind (Tamarindus indica) seed”. Molecules (Basel, Switzerland) 24.7 (2019): 1218.
212. Wang S., et al. “Chemical constituents and health effects of sweet potato”. Food Research International1 (2016): 90-116.
213. Fatma M., et al. “Ethylene signaling under stressful environments: Analyzing collaborative knowledge”. Plants (Basel, Switzerland)17 (2022): 2211.
214. Naito Y., et al. “Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients”. Journal of Clinical Gastroenterology1 (1992): S131-S134.
215. Norris SH and Hersey SJ. “pH dependence of pepsinogen and acid secretion in isolated gastric glands”. The American Journal of Physiology 6 (1983): G730-G738.
216. Darling RA., et al. “Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors”. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 1 (2014): R35-R43.
217. Browning KN and Travagli RA. “Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions”. Comprehensive Physiology4 (2014): 1339-1368.
218. Dangles O and Fenger JA. “The chemical reactivity of anthocyanins and its consequences in food science and nutrition”. Molecules (Basel, Switzerland)8 (2018): 1970.
219. Afrin S., et al. “Promising health benefits of the strawberry: a focus on clinical studies”. Journal of Agricultural and Food Chemistry22 (2016): 4435-4449.
220. Giampieri F., et al. “Strawberry as a health promoter: an evidence based review”. Food and Function5 (2015): 1386-1398.
221. Hannum SM. “Potential impact of strawberries on human health: a review of the science”. Critical Reviews in Food Science and Nutrition 1 (2004): 1-17.
222. Alajil O., et al. “Nutritional and phytochemical traits of apricots (Prunus armeniaca) for application in nutraceutical and health industry”. Foods (Basel, Switzerland) 10.6 (2021): 1344.
223. Al-Soufi MH., et al. “A review with updated perspectives on nutritional and therapeutic benefits of apricot and the industrial application of its underutilized parts”. Molecules (Basel, Switzerland)15 (2022): 5016.
224. Xu M., et al. “Transcriptome analysis insight into ethylene metabolism and pectinase activity of apricot (Prunus armeniaca ) development and ripening”. Scientific Reports 11.1 (2021): 13569.
225. D'Ambrosio C., et al. “Proteomic analysis of apricot fruit during ripening”. Journal of Proteomics 78 (2013): 39-57.
226. Su C., et al. “Comparison of phenolic composition, vitamin C, antioxidant activity, and aromatic components in apricots from Xinjiang”. Journal of Food Science1 (2022): 231-250.
227. Alasalvar C., et al. “Specialty seeds: Nutrients, bioactives, bioavailability, and health benefits: A comprehensive review”. Comprehensive Reviews in Food Science and Food Safety3 (2021): 2382-2427.
228. Balakrishna R., et al. “Consumption of nuts and seeds and health outcomes including cardiovascular disease, diabetes and metabolic disease, cancer, and mortality: an umbrella review”. Advances in Nutrition (Bethesda, Md.) 6 (2022): 2136-2148.
229. Rab FA. “Would science knowledge, food and agriculture sector be considered basic human services or commercial services in this post covid19 era? decision will determine the destination”. EC Nutrition10 (2023): 01-08.
230. Rab FA. “Socio economic status lost connection with healthy and nutritious diet consumption practices”. EC Nutrition 11 (2024): 01-04.
231. Rab FA. “Role of food-its influence on modulation of therapies including chemotherapy’s outcomes”. EC Nutrition2 (2025): 01-31.
232. Rab FA. “Universal evolutionary capacitor switch operation regulation gimmicks driving illness and natural cure: food and environment are the key modulating drivers”. EC Nutrition2 (2026): 01-28.
233. Rab FA. “Nutrition science-an altered evolving role in maintaining natural health driving illnesses and cure”. EC Nutrition3 (2026): 01-28.
234. Xu M., et al. “Exploiting phenotypic heterogeneity to improve production of glutathione by yeast”. Microbial Cell Factories 1 (2024): 267.
235. Kozlov M. “COVID can wake up a slew of dormant viruses inside you”. Nature8127 (2026): 281-282.